DISPOSABLE SYRINGES MARKET ANALYSIS

The global Disposable Syringes Market is estimated to be valued at US$ 8.8 billion in 2023 and is expected to exhibit a CAGR of 6.6% during the forecast period (2023-2030).

Analysts’ Views on Global Disposable Syringes Market:

The market is primarily being driven by the rising prevalence of chronic diseases, the rising manufacturing, and the rising demand for injectable drugs, which is attributed to the growth of the global disposable syringes market over the forecast period. For instance, in March 2020, Xellia Pharmaceuticals, a specialty pharmaceutical company, received the U.S. Food and Drug Administration (FDA) approval to commence manufacturing of aseptic injectable at its Cleveland, Ohio site, U.S.

Figure 1. Global Disposable Syringes Market Share (%), by Product Type, 2023

To learn more about this report, request sample copy

Global Disposable Syringes Market – Driver

Increasing Inorganic Growth Strategies by Market Players

Increasing inorganic growth strategies by market players is expected to propel growth of the global disposable syringes market over the forecast period. For instance, in December 2022, Sharps Technology, Inc., an innovative medical device and drug Delivery Company offering patented, best-in-class syringe products, announced the signing of a distribution agreement with partner Nephron Pharmaceuticals. This is a strategic first step in building the larger partnership between the two companies and is in support of their recently announced collaboration. Through this distribution plan, Sharps Technology will be able to deliver increased capacity, driving growth for one of the high value product segments of our business. The agreement also allows for Sharps Technology to utilize Nephron's sales and marketing teams to further support the sale of the Company’s innovative products to targeted customers within the Nephron customer network.

Increase in Geriatric population

According to CDC (Centers for Disease Control and Prevention), adults aged 65 years and above are more likely to acquire heart disease, COPS, diabetes, cancer, neurological problems, and other chronic illnesses. Patients with such illnesses require emergency and nonemergency hospital services which is expected to spur the market growth soon. For instance, in 2020, according to Front. Public Health in 2020, Ischemic heart disease, stroke, chronic obstructive pulmonary disease (COPD), and type 2 diabetes are the most prevalent chronic NCDs in China among persons aged 60. Additional factors driving market growth include the ongoing development of medical infrastructure as well as rising public and private sector investments to encourage the use of safer and more affordable healthcare solutions.

Figure 2. Global Disposable Syringes Market Value (US$ Billion), by Region, 2023

To learn more about this report, request sample copy

Global Disposable Syringes Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global Disposable Syringes Market over the forecast period. North America is estimated to hold 42.5% of the market share in 2023. The growing prevalence of chronic diseases and spine disorders directly impacts the increased demand for the disposable syringes. For instance, in July 2022, according to an article published by StatPearls publishing, in North America, billions of healthcare workers use syringes in their daily work, and hence, the risk of needlestick injuries is always a concern. While the introduction of universal precautions and safety conscious syringes designs has led to a decline in needlestick injuries. However, the major concern after a needlestick injury is not HIV but hepatitis B or hepatitis C.

Global Disposable Syringes Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others are facing problems with the transportation of drugs from one place to another.

However, the COVID-19 pandemic had a positive impact on the global disposable syringes market. For instance, in July 2020, BARDA (Biomedical Advanced Research and Development Authority) and JPEO-CBRND (Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense) established a partnership with BD (Becton Dickinson Co.), a multinational medical technology company, to expand domestic manufacturing capacity for needles and syringes. With this agreement, BARDA, JPEO-CBRND, and BD had taken steps to improve the capacity to produce safety syringes and needles, reducing reliance on foreign nations to supply these vital supplies. As existing supplies are consumed in ordinary healthcare and to treat the influx of COVID-19 patients, this expansion is even more crucial during the COVID-19 pandemic. BARDA, a U.S. Department of Health and Human Services office responsible for the procurement and development of medical countermeasures, whereas JPEO-CBRND investments in chemical, biological, radiological, and nuclear (CBRN) defense equipment and medical countermeasures.

Global Disposable Syringes Market Segmentation:

The global disposable syringes market report is segmented into by Product Type and by Region.

By Product Type, the market is segmented into Safety Syringes and Conventional Syringes. Out of which, the  Safety syringes segment is expected to hold a dominant position in the global disposable syringes market during the forecast period and owing to large volume of safety syringes that are being used in healthcare industries for diverse medical conditions.

By Region, the North America is expected to dominate the market over the forecast period and this is attributed due to the increasing prevalence of chronic diseases along with the increasing demand for injectable drugs.

Among all the segmentations, the safety syringe segment has the highest potential to dominate due to the increasing prevalence of chronic diseases such as hepatitis B and C, HIV, and so on, over the forecast period. For instance, in June 2022, according to the WHO (World Health Organization) World Hepatitis Summit 2022, it is estimated that 354 billion people globally are still living with this life-threatening infection and at least one person dies from viral hepatitis every 30 seconds, that is over 1 billion deaths per year–a greater toll than that from HIV and malaria combined.

Global Disposable Syringes Market Cross Sectional Analysis:

Rising incidence of chronic diseases like HIV, cancer, hepatitis and spine disorders in emerging economies is also expected to boost demand for disposable syringes in North America region. For instance, in For instance, on January 25 2023, KORU Medical Systems, Inc., a medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, announced a development agreement with a pharmaceutical manufacturer of subcutaneous immunoglobulin therapy (SCIg) to develop and seek regulatory approval of the Freedom Infusion System with an SCIg prefilled syringe.

Global Disposable Syringes Market: Key Developments

On January 24 2023, Stevanato Group, a global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences industries, announced its latest collaboration with Transcoject GmbH, a medical device and pharma packaging Solutions Company. The collaboration will enable Stevanato Group to add cyclic olefin polymer (COP) and cyclic olefin copolymer (COC) PFS to its existing portfolio of solutions providing added value in the customers’ supply chain. By integrating Transcoject's technological know-how with Stevanato Group’s capabilities and expertise–in drug containment solutions, manufacturing and market trends-Stevanato Group will be able to offer pre-fillable syringes in glass and in both COP and COC polymers.

In May 2022, Owen Mumford, a global company specialized in the design, development and manufacture of injectable drug delivery systems for the pharmaceutical, biotech and generics industries, has signed an exclusive agreement with Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions for the Aidaptus auto-injector. The agreement makes Stevanato Group an exclusive manufacturing partner for the Owen Mumford designed auto-injector, offering a full set of capabilities to its pharmaceutical customers.

On March 16 2023, Stevanato Group S.p.A., a global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced a collaboration with Recipharm AB, a Contract Development and Manufacturing Organization (CDMO). Under the agreement, Stevanato Group will lend its manufacturing experience to support the development and production of pre-fillable syringes for use in Recipharm’s soft mist inhalers. As part of this collaboration, Stevanato Group will provide and manufacture its glass pre-fillable syringe Alba assembled with the Integrated Spray Module (ISMTM) of Recipharm’s soft mist inhaler technology, the Pre-Filled Syringe Inhaler (PFSITM).

On April 13 2023, Delta Med Group, a manufacturer of medical devices and DBM, a manufacturer of pre-filled syringes announced a strategic partnership to strengthen their positioning in the pre-filled syringes market. Delta Med Group and DBM will expand their portfolio profiting from highly complementary products and R&D capabilities, improving their ability to serve customers. The partnership will generate significant synergies and boost the growth trajectory of the combined entity.

Global Disposable Syringes Market: Key Trends

High prevalence of needlestick injuries in emerging economies

The increasing prevalence of chronic diseases is driving the demand for Disposable Syringes as a means of reducing the risk of needlestick injuries and blood borne pathogen exposure in both patients and healthcare workers. For instance, in October 2021, according to an article published on the journal of (BMC) BioMed Health Services Research, increasing incidence of NSIs (Needle Sticks Injuries) over 26 months was 8.4% among all participants. Nurses were the most affected staff (52.5%) resulted commonly from disposing syringes (58.9%). In contrast, the incidence of NSIs among physicians was 24.9% where surgical devices were the primary source of NSIs among them (40%).

Effective Government Policies

Effective government policy such as awareness about the proper usage of needles, running campaigns for the safety measures, and so on is expected to drive the global safety needle market. For instance, in April 2022, American Medical Association (AMA) urges states to adopt new Maine needle, syringe exchange policy to modify restrictive laws and regulations concerning the sale and possession of needles and syringes to maximize the availability of sterile syringes and needle.

Global Disposable Syringes Market: Restraint

Increasing concerns over medical waste accumulation

Improper management of discarded needles and other sharps can pose a health risk to the public and waste workers. For example, discarded needles may expose waste workers to potential needle stick injuries and potential infection when containers break open inside garbage trucks or needles are mistakenly sent to recycling facilities. Taking initiative for the medical wastes disposal like incineration. For instance, in February 2022, according to World Health Organization (WHO), approximately 87,000 tons of personal protective equipment (PPE) were purchased between March 2020 and November 2021 and transported to address nations' urgent COVID-19 response needs through a combined UN (United Nations) emergency plan. It's anticipated that the majority of this equipment was wasted. 60% of healthcare institutions in the least developed countries are ill-prepared to handle even the current waste loads, much less the increased COVID-19 load, at 30% of their facilities. This could expose health professionals to needle stick injuries, burns, and harmful microbes. It could also have an effect on the populations living next to poorly managed landfills and garbage disposal sites by contaminating the air from burning waste, degrading the water, or attracting pests that spread illness.

Global Disposable Syringes Market - Key Players

Major players operating in the global disposable syringes market include B. Braun SE, BD (Becton, Dickinson and Company), CODAN Medizinische Geräte GmbH, Gerresheimer AG, Medtronic, Retractable Technologies, Inc., Star Syringe Limited, ICU Medical, Inc., Terumo Corporation, and Sulzer Ltd.